100 likes | 214 Views
This document outlines the 2010 changes in reporting Invasive Pneumococcal Disease (IPD) to the National Notifiable Diseases Surveillance System. Key updates include the discontinuation of separate reporting for drug-resistant cases, and all cases must now be reported under a single condition: Streptococcus pneumoniae, invasive disease. The latest NBS upgrade (version 3.1.1) is discussed, with details on case definition, provider education, and antimicrobial resistance testing requirements provided.
E N D
Invasive Pneumococcal Disease (IPD)-2010 Veerinder (Vinny) Taneja PHIN Coordinator CEDS TN-DOH Vinny.Taneja@tn.gov
Background • List of Nationally Notifiable Infectious Disease Conditions is updated periodically • Additions/Deletions • Emerging Pathogens or decreasing incidence • State-CDC-CSTE collaboration
2010 Changes for IPD • All cases of invasive pneumococcal disease should be reported using a SINGLE condition: • Streptococcus pneumoniae, invasive disease (IPD) (all ages) • The classification of invasive pneumococcal disease cases into two separate conditions should be discontinued • Streptococcus pneumoniae, drug resistant, invasive (DRSP) • Streptococcus pneumoniae, invasive
Changes to NBS • NBS was recently upgraded to version 3.1.1 on 03/19/2010 • All 3 conditions are now available in NBS under the Select Condition drop down
Changes to NBS- IPD • 2 of the old conditions will soon be disabled • Changes to case definition • Confirmed: Isolation of Streptococcus pneumoniae from a normally sterile body site in a person of any age. • Disease manual update and updated reportable conditions list • Provider education about reporting IPD and antibiotic testing results
NBS data entry changes • Leave all previously entered 2010 cases as is (MAKE NO CHANGES) • Enter all new cases of Invasive Pneumococcal Disease as • Streptococcus Pneumoniae, Invasive Disease (IPD) • Enter Antimicrobial Resistance Testing Results
Recommended Antibiotic Results • The antibiograms for S. pneumo are recommended to include the following: • ceftriaxone • erythromycin or clindamycin • levofloxacin • penicillin • tetracycline • meropenem DRSP is defined as resistance to one or more of the antibiotics commonly used to treat Strep Pneumo.
Data Analysis • For years 2009 and prior the two old conditions will be used • For 2010 all three conditions will be used • For 2011 the new IPD condition will be used • Stratify by resistant and sensitive
References • National Notifiable Diseases Surveillance System http://www.cdc.gov/ncphi/disss/nndss/nndsshis.htm • CSTE Position Statement Number: 09-ID-06 http://www.cste.org/ps2009/09-ID-06.pdf